New device ROTEM® platelet

Tem International GmbH provides the new ROTEM® platelet module as from November 2013.
The ROTEM® platelet measures platelet aggregation in whole blood samples using impedance aggregometry.
The new device is run in conjunction with the ROTEM® delta, and is compatible with all existing ROTEM® delta models with serial numbers > 2000.
The ROTEM® platelet supplements the platelet function analysis in the ROTEM® – guided peri-operative bleeding management.

more information

27. November 2013|Product News|

ROTEM® News 02-2013

The current issue focusses on the topic European guidelines for severe bleeding management.
In this newsletter we highlight recommendations of recently published European guidelines
for severe bleeding management dealing with the use of viscoelastic testing and goal-directed
therapy in clinical settings.


21. November 2013|Miscellaneous news|

ROTEM® News 01-2013

The current issue focusses on the topic trauma.

Besides an interview with Dr. Herbert Schöchl, anesthetist and intensivist from Salzburg (Austria), we present an interesting case report in the section “Interpretation Guide” for you. A current recommended reading from the Scandinavian Journal of Trauma, entitled “Early and individualized goal-directed therapy for trauma-induced coagulopathy” is pointed out.


5. April 2013|Miscellaneous news|

ROTEM® News 03-2012

In this and the coming newsletters, specific topics will be discussed.

The current issue focusses on the topic post-partum haemorrhage.
Besides an interesting interview with Dr. Alexander Hanke, anesthesiologist and intensivist from Hannover Medical School (Germany), we provide an interesting case study in the section “Interpretation Guide” for you.

For the full ROTEM® News click here.

19. December 2012|Miscellaneous news|

Tem Innovations GmbH receives approval for the ROTEM® delta system in Canada

Munich, Germany (23. September 2012):
The Canadian regulatory authority Health Canada has approved the sale of the ROTEM® delta hemostasis analyzer system of Tem Innovations GmbH in Canada. Therefore another global market can benefit from the ROTEM® delta system as an ideal analysis tool for rapid and effective blood management. The ROTEM® delta unit with its unique five assays (in-tem®, ex-tem®, hep-tem®, fib-tem® and ap-tem®)  provides detailed hemostasis information to physicians in cardiac and vascular surgery,   tumor resection or transplantation, orthopedic surgery, trauma care and obstetrics. With more detailed hemostasis information at the clinician’s disposal, patient outcomes have been shown to improve and hospital expenses related to blood products decrease.


23. September 2012|Company News|

ROTEM® News 02-2012

Besides an exciting interview about the implementation of a ROTEM® system in the clinical practice with Dr. Lynne Anderson, we provide new practical interpretation cases for you.

In the column “frequently asked question of the month” the customer service explains the data export from the database.

recent prospective randomized study of the university hospital Frankfurt am Main on “Point-of-Care Testing” will be presented in the literature section.

Moreover, we inform you about the upcoming international conferences and events.


17. September 2012|Miscellaneous news|

ROTEM® Expert Meeting for the Asian-Pacific Region

It is with great pleasure to announce that Tem International GmbH will initiate a ROTEM® Expert Meeting for the Asian- Pacific Region in 2012.
The meeting is based on the idea that leading ROTEM®-Experts from Europe share their knowledge gained over many years now with ROTEM® users or opinion leaders from countries of the Asian-Pacific-Region. Lectures and workshops will be based on peri-operative coagulation management in the field of cardiac surgery, liver transplantation, trauma, obstetric, orthopaedic and visceral surgery.
The meeting will take place in Bangkok, October, 25th to 26th 2012.
European as well as Asian anaesthetists will chair the meeting.
We look forward to welcoming many ROTEM® users and opinion leaders in Bangkok for an interesting and successful meeting.

Dr. Thomas Ebinger (CEO), Dr. Klaus Görlinger (Clinical Director) and Elfriede Steffan (Manager Commercial Development)

Download program

29. August 2012|Miscellaneous news|

Einweihung des ROTEM® System im Klinikum Ansbach


14. June 2012|Miscellaneous news|
  • TEM-UK-2012-Hartlepool-Business-Awards
    Permalink Gallery

    TEM UK Ltd – winners of the award in the category “most promising new business 2012″

TEM UK Ltd – winners of the award in the category “most promising new business 2012″

Company director Alby Pattison says: “We are two years in, and going the way we are, next year could be even more exciting. The future is looking really good for TEM”.

View the news report

View the certificate

25. May 2012|Company News|

Press Release: Dr. Klaus Görlinger appointed new clinical director

Munich, Germany (April 26, 2012):

Dr. Klaus Görlinger has been appointed new clinical director at Tem International GmbH in Munich as of  1st of July 2012.

“Increasing challenges in the development and additional requirements worldwide as a consequence of the FDA approval last year, require the reinforcement of new employees. Induced by the expanded collaboration with Dr. Görlinger we succeeded to strengthen our team with a very highly qualified and experienced clinical director”
said Dr. Thomas Ebinger, CEO of Tem International GmbH.

read more

26. April 2012|Company News|